The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form” global category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
How do biotech and pharma sponsors benefit from Accelerator™ Drug Development?
Video
Biotech and biopharma sponsors partnering with Thermo Fisher Scientific through our Accelerator™ Drug Development’s 360° CDMO and CRO solutions gain numerous benefits, including speed, flexibility, and cost savings. From process development to commercial manufacturing, there are opportunities for improvement throughout the drug development journey.
In a recent video, Jennifer Cannon, president of commercial operations, pharma services at Thermo Fisher Scientific, discusses findings from a recent study by the Tufts Center for Drug Development, focusing on oncology. She demonstrates how an integrated CDMO and CRO approach can help reduce clinical drug development timelines by an average of 7-19 months.
See more:
Video